Bausch Health to Announce First Quarter Results on April 30
NYSE - LSE
| RBGPF | -1.52% | 73.88 | $ | |
| BCC | 1.94% | 88.14 | $ | |
| NGG | -0.11% | 72.15 | $ | |
| GSK | -0.68% | 37.97 | $ | |
| JRI | -0.46% | 13.09 | $ | |
| SCS | 0.66% | 10.58 | $ | |
| CMSC | 0.24% | 22.485 | $ | |
| RELX | -1.86% | 52.73 | $ | |
| RIO | -1.16% | 63.1 | $ | |
| SCU | 0% | 12.72 | $ | |
| RYCEF | -0.3% | 13.2 | $ | |
| CMSD | 0.17% | 22.89 | $ | |
| BCE | -0.95% | 24.2 | $ | |
| BTI | -0.71% | 52.25 | $ | |
| VOD | -0.79% | 11.43 | $ | |
| AZN | -1.4% | 72.66 | $ | |
| BP | 0.22% | 32.2 | $ |
Bausch Health to Announce First Quarter Results on April 30
LAVAL, QC / ACCESS Newswire / March 27, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release first quarter financial results after market close on Wednesday, April 30, 2025. Bausch Health will host a conference call and live webcast at 5:00 p.m. U.S. EDT to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.
Conference Call Details
Date: | Wednesday, April 30, 2025 |
Time: | 5:00 p.m. U.S. EDT |
Webcast: |
A replay of the conference call will be available on the investor relations website.
About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit www.bauschhealth.com and connect with us on LinkedIn.
Investor Contact: | Media Contact: |
Garen Sarafian | Katie Savastano |
(877) 281-6642 (toll-free) | (908) 541-3785 |
SOURCE: Bausch Health Companies Inc
View the original press release on ACCESS Newswire
M.Moreau--JdCdC
